Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Effects of Moxaverine and Placebo on Ocular Blood Flow
Phase 2
Completed
- Conditions
- Regional Blood FlowOcular PhysiologyRetina
- Interventions
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2008-07-03
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 16
- Registration Number
- NCT00709423
- Locations
- 🇦🇹
Department of Clincal Pharmacology, Medical University of Vienna, Vienna, Austria
Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid?
Not Applicable
Completed
- Conditions
- Genetic PolymorphismMacular DegenerationRegional Blood FlowOcular Physiology
- Interventions
- Procedure: Squatting
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2013-03-19
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 100
- Registration Number
- NCT00708929
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Rapid Effects of Hydrocortisone on Glucose-induced Insulin Secretion in Healthy Humans
Phase 4
Completed
- Conditions
- Healthy
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2011-06-01
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 10
- Registration Number
- NCT00709839
- Locations
- 🇦🇹
Division of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
Phase 2
Completed
- Conditions
- Macular DegenerationGlaucomaRegional Blood Flow
- Interventions
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2009-12-01
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT00709449
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
Not Applicable
Terminated
- Conditions
- Regional Blood FlowVascular Endothelial Growth FactorMacular Degeneration
- Interventions
- Drug: ranibizumab, bevacizumab or pegaptanib
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 8
- Registration Number
- NCT00709657
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients
Phase 4
Completed
- Conditions
- Systemic Inflammatory Response Syndrome
- Interventions
- Drug: Albumin (5% serum-protein solution containing immunoglobulins)
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2008-07-02
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 40
- Registration Number
- NCT00708747
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head?
Early Phase 1
Terminated
- Conditions
- Ocular PhysiologyRegional Blood Flow
- Interventions
- First Posted Date
- 2008-07-02
- Last Posted Date
- 2014-11-17
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 12
- Registration Number
- NCT00708357
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Vienna, Austria
Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes
Completed
- Conditions
- Glaucoma, Open-AngleIntraocular PressureRegional Blood FlowCircadian Rhythm
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2008-06-30
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT00707226
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Not Applicable
Completed
- Conditions
- RetinaOcular Physiology
- First Posted Date
- 2008-06-30
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 16
- Registration Number
- NCT00706927
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Vienna, Austria
Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus
Terminated
- Conditions
- Diabetic Retinopathy
- First Posted Date
- 2008-06-25
- Last Posted Date
- 2015-04-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 5
- Registration Number
- NCT00704652
- Locations
- 🇦🇹
Departmen of Ophthalmology, Medical Unversity of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath